Inspire Medical Systems announced that Aetna will provide coverage for its Inspire therapy for obstructive sleep apnea.
The coverage for the company's hypoglossal nerve neurostimulation device will begin immediately. Under the policy, the insurer considers treatment to be medically necessary when certain criteria are met, according to Inspire Medical. These criteria include, but may not be limited to, a previous attempt at continuous positive airway pressure treatment and patient selection consistent with U.S. Food and Drug Administration-approved guidelines.
